Literature DB >> 7296566

4-Methylumbelliferyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside, a fluorogenic substrate for N-acetyl-alpha-D-glucosaminidase.

P Chow, B Weissmann.   

Abstract

Condensation of dimeric 3,4,6-tri-O-acetyl-2-deoxy-2-nitroso-alpha-D-glucopyranosyl chloride with 4-methylumbelliferone gave crystalline 4-methylumbelliferyl 3,4,6-tri-O-acetyl-2-deoxy-2-oximino-alpha-D-arabino-hexopyranoside. Acetylation of this adduct, reduction of the resulting crude O-acetyloxime with borane in oxolane, and acetylation gave the 3,4,6-tri-O-acetyl derivative of 4-methylumbelliferyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside (1). A new sensitive assay of N-acetyl-alpha-D-glucosaminidase (EC 3.2.1.50) is made possible by fluorometric measurement of 4-methylumbelliferone liberated by enzymic hydrolysis of glycoside 1. Such assays are illustrated by results obtained with enzyme preparations from pig liver and human-blood serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296566     DOI: 10.1016/s0008-6215(00)84698-4

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.

Authors:  H H Li; W H Yu; N Rozengurt; H Z Zhao; K M Lyons; S Anagnostaras; M S Fanselow; K Suzuki; M T Vanier; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  NAGLU mutations underlying Sanfilippo syndrome type B.

Authors:  A Schmidtchen; D Greenberg; H G Zhao; H H Li; Y Huang; P Tieu; H Z Zhao; S Cheng; Z Zhao; C B Whitley; P Di Natale; E F Neufeld
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

3.  Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.

Authors:  Guglielmo R D Villani; Antonia Follenzi; Borghina Vanacore; Carmela Di Domenico; Luigi Naldini; Paola Di Natale
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

4.  Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.

Authors:  Ekram Fateen; Zeinab Y Abdallah; Walaa S Nazim; Mona Ibrahim; Amira Radwan
Journal:  Heliyon       Date:  2021-08-19

5.  Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts.

Authors:  Shih-hsin Kan; Larisa A Troitskaya; Carolyn S Sinow; Karyn Haitz; Amanda K Todd; Ariana Di Stefano; Steven Q Le; Patricia I Dickson; Brigette L Tippin
Journal:  Biochem J       Date:  2014-03-01       Impact factor: 3.857

6.  Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients.

Authors:  A Tessitore; G R Villani; C Di Domenico; M Filocamo; R Gatti; P Di Natale
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

7.  A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.

Authors:  Victor Mauri; Parisa Lotfi; Laura Segatori; Marco Sardiello
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.